Hikma Pharmaceuticals Plc HKMPY reported a 19% surge in its full-year profit.
Hikma's profit attributable to shareholders climbed to $120.5 million, up from $100.9 million in the year-ago period.
Its revenue rose 21% to $1.11 billion.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
